The role of oligodendroglial dysfunction in Huntington's disease

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Huntington's disease (HD) is a fatal neurodegenerative disorder primarily studied for neuronal pathology.
• Oligodendrocytes, the myelin-producing cells of the central nervous system, are increasingly recognized for their role in HD pathogenesis.
• White matter abnormalities and oligodendrocyte dysfunction are now understood to be early events in HD progression.

Purpose of the Study:

• To review and synthesize recent findings on oligodendroglial dysfunction in Huntington's disease.
• To highlight the early onset of white matter abnormalities in HD.
• To explore the molecular mechanisms underlying oligodendrocyte dysfunction in HD.

Main Methods:

• Review of neuroimaging and postmortem studies in HD patients and animal models.
• Analysis of molecular and genetic studies investigating oligodendroglial function in HD.
• Examination of epigenetic modifications, gene regulation, and signaling pathways affecting oligodendrocytes.

Main Results:

• White matter abnormalities, including atrophy and myelin breakdown, are early indicators in HD, preceding gray matter changes.
• Mutant huntingtin disrupts oligodendrocyte function via transcriptional dysregulation, epigenetic changes (PRC2, REST), altered lipid metabolism, and impaired BDNF signaling.
• Key oligodendroglial regulators (MYRF, TCF7L2) are compromised, leading to defective myelination and reduced neuronal support.

Conclusions:

• Oligodendroglial dysfunction is a critical early event in Huntington's disease pathogenesis.
• Understanding these glial mechanisms provides potential biomarkers for early HD detection.
• Targeting oligodendrocytes and white matter integrity represents a promising therapeutic strategy for HD.